|
2019 Journal Article New treatment paradigms for clinically apparent metastatic melanoma in regional lymph nodesHenderson, Michael A., Spillane, John, Hughes, T. Michael, Spillane, Andrew J., Smithers, B. Mark and Thompson, John F. (2019). New treatment paradigms for clinically apparent metastatic melanoma in regional lymph nodes. ANZ Journal of Surgery, 89 (10), 1187-1189. doi: 10.1111/ans.15407 |
|
2019 Journal Article Clinicopathological factors associated with death from thin (≤ 1·00 mm) melanomaClaeson, M., Baade, P., Brown, S., Soyer, H. P., Smithers, B. M., Green, A. C., Whiteman, D. C. and Khosrotehrani, K. (2019). Clinicopathological factors associated with death from thin (≤ 1·00 mm) melanoma. British Journal of Dermatology, 182 (4) bjd.18560, 927-931. doi: 10.1111/bjd.18560 |
|
2019 Journal Article The impact of signet ring cell differentiation on outcome in patients with esophageal and gastroesophageal junction adenocarcinomavan Hootegem, Sander J. M., Smithers, B. Mark, Gotley, David C., Brosda, Sandra, Thomson, Iain G., Thomas, Janine M., Gartside, Michael, van Lanschot, Jan J. B., Lagarde, Sjoerd M., Wijnhoven, Bas P. L. and Barbour, Andrew P. (2019). The impact of signet ring cell differentiation on outcome in patients with esophageal and gastroesophageal junction adenocarcinoma. Annals of Surgical Oncology, 26 (8), 2375-2384. doi: 10.1245/s10434-019-07322-x |
|
2019 Journal Article Multidisciplinary cancer care in AustraliaWalpole, Euan, Smithers, Mark, Cossio, Danica, Harden, Hazel, Thiele, David and Janda, Monika (2019). Multidisciplinary cancer care in Australia. Asia-Pacific Journal of Clinical Oncology, 15 (4), 197-198. doi: 10.1111/ajco.13164 |
|
2019 Journal Article IRF4 rs12203592*T/T genotype is associated with nodular melanomaRayner, Jenna E., McMeniman, Erin K., Duffy, David L., De'Ambrosis, Brian, Smithers, B Mark, Jagirdar, Kasturee, Lee, Katie J., Soyer, H Peter and Sturm, Richard A. (2019). IRF4 rs12203592*T/T genotype is associated with nodular melanoma. Melanoma Research, 29 (4), 445-446. doi: 10.1097/CMR.0000000000000596 |
|
2019 Journal Article Future is bright for academic surgery in Australasia: highlights of the 2018 Academic MeetingsLee, James C., Mukherjee, Payal, Koh, Cherry and Smithers, Mark (2019). Future is bright for academic surgery in Australasia: highlights of the 2018 Academic Meetings. ANZ Journal of Surgery, 89 (7-8), 798-799. doi: 10.1111/ans.15341 |
|
2019 Journal Article Phenotypic and genotypic analysis of amelanotic and hypomelanotic melanoma patientsRayner, J. E., McMeniman, E. K., Duffy, D. L., De'Ambrosis, B., Smithers, B. M., Jagirdar, K., Lee, K. J., Soyer, H. P. and Sturm, R. A. (2019). Phenotypic and genotypic analysis of amelanotic and hypomelanotic melanoma patients. Journal of the European Academy of Dermatology and Venereology, 33 (6) jdv.15446, 1076-1083. doi: 10.1111/jdv.15446 |
|
2019 Journal Article Conclusions from quality of life studies in patients with resected high-risk melanoma: one part of the full storySmithers, B. Mark (2019). Conclusions from quality of life studies in patients with resected high-risk melanoma: one part of the full story. The Lancet Oncology, 20 (5), 611-612. doi: 10.1016/S1470-2045(19)30176-7 |
|
2019 Journal Article Evaluation of the efficacy and toxicity of upper extremity isolated limb infusion chemotherapy for melanoma: an Australian multi-center studyKroon, Hidde M., Coventry, Brendon J., Henderson, Michael A., Barbour, Andrew, Serpell, Jonathan, Smithers, B. Mark and Thompson, John F. (2019). Evaluation of the efficacy and toxicity of upper extremity isolated limb infusion chemotherapy for melanoma: an Australian multi-center study. European Journal of Surgical Oncology, 45 (5), 832-837. doi: 10.1016/j.ejso.2019.02.026 |
|
2019 Journal Article Risk of melanoma recurrence after diagnosis of a high-risk primary tumorVon Schuckmann, Lena A., Hughes, Maria Celia B., Ghiasvand, Reza, Malt, Maryrose, Van Der Pols, Jolieke C., Beesley, Vanessa L., Khosrotehrani, Kiarash, Smithers, B. Mark and Green, Adele C. (2019). Risk of melanoma recurrence after diagnosis of a high-risk primary tumor. JAMA Dermatology, 155 (6), 688-693. doi: 10.1001/jamadermatol.2019.0440 |
|
2019 Conference Publication ANZMTG 01.09 An International randomised trial of post-operative radiation therapy following wide excision of neurotropic melanoma of the head and neckFoote, M., Smithers, M., Hong, A., Fogarty, G., Scolyer, R., Paton, E., Barker, C., Chua, M., Shannon, K., Burmeister, B. and Nobes, J. (2019). ANZMTG 01.09 An International randomised trial of post-operative radiation therapy following wide excision of neurotropic melanoma of the head and neck. HOBOKEN: WILEY. |
|
2019 Journal Article Long–term oncologic outcomes after isolated limb infusion for locoregionally metastatic melanoma: an international multicenter analysisMiura, John T., Kroon, Hidde M., Beasley, Georgia M., Mullen, Dean, Farrow, Norma E., Mosca, Paul J., Lowe, Michael C., Farley, Clara R., Kim, Youngchul, Naqvi, Syeda Mahrukh Hussnain, Potdar, Aishwarya, Daou, Hala, Sun, James, Farma, Jeffrey M., Henderson, Michael A., Speakman, David, Serpell, Jonathan, Delman, Keith A., Smithers, B. Mark , Coventry, Brendon J., Tyler, Douglas S., Thompson, John F. and Zager, Jonathan S. (2019). Long–term oncologic outcomes after isolated limb infusion for locoregionally metastatic melanoma: an international multicenter analysis. Annals of Surgical Oncology, 26 (8), 2486-2494. doi: 10.1245/s10434-019-07288-w |
|
2019 Journal Article Predictors of staging accuracy, pathologic nodal involvement, and overall survival for cT2N0 carcinoma of the esophagusAtay, Scott M., Correa, Arlene, Hofstetter, Wayne L., Swisher, Stephen G., Ajani, Jaffer, Altorki, Nassar K., Blackmon, Shanda H., Blackstone, Eugene H., Rice, Thomas W., Crabtree, Traves D., D'Amico, Thomas A., Darling, Gail E., DeMeester, Steven R., DeMeester, Thomas R., Worrell, Stephanie G., Ferri, Lorenzo E., Gaissert, Henning A., Krasna, Mark J., Lerut, Antoon, Nafteux, Phillippe, Moons, Johnny, Little, Alex G., Low, Donald E., Carrott, Phillip W., Schmidt, Henner M., Miller, Daniel, Nason, Katie S., Luketich, James D., Orringer, Mark B. ... Yang, Stephen C. (2019). Predictors of staging accuracy, pathologic nodal involvement, and overall survival for cT2N0 carcinoma of the esophagus. Journal of Thoracic and Cardiovascular Surgery, 157 (3), 1264-1272.e6. doi: 10.1016/j.jtcvs.2018.10.057 |
|
2019 Journal Article A systematic review and meta-analysis of locoregional treatments for in-transit melanomaRead, Tavis, Lonne, Michael, Sparks, David S., David, Michael, Wagels, Michael, Schaider, Helmut, Soyer, H. Peter and Smithers, B. Mark (2019). A systematic review and meta-analysis of locoregional treatments for in-transit melanoma. Journal of Surgical Oncology, 119 (7) jso.25686, 887-896. doi: 10.1002/jso.25400 |
|
2019 Conference Publication Obesity Paradox in Early Stage Melanoma: Long-Term Follow-up in MSLT-IRand, J. G., Kirchoff, D., Deutsch, G., Stern, S., Thompson, J., Cochran, A., Mozzillo, N., Nieweg, O., Roses, D., Hoekstra, H., Sondak, V., Coventry, B., Kashani-Sabet, M., Smithers, M., Paul, E., Kraybill, W., Elashoff, R., Lee, D. and Faries, M. B. (2019). Obesity Paradox in Early Stage Melanoma: Long-Term Follow-up in MSLT-I. 72nd Annual Cancer Symposium of the Society-of-Surgical-Oncology (SSO), San Diego Ca, Mar 27-30, 2019. NEW YORK: SPRINGER. |
|
2019 Conference Publication Patterns of response for combination of PV-10 oncolytic immunotherapy and checkpoint inhibitionAgarwala, Sanjiv S., Ross, Merrick I., Zager, Jonathan, Shirai, Keisuki, Essner, Richard, Smithers, Bernard M., Atkinson, Victoria, Sarson, David and Wachter, Eric A. (2019). Patterns of response for combination of PV-10 oncolytic immunotherapy and checkpoint inhibition. LONDON: BMC. |
|
2019 Journal Article Patients with in-transit melanoma metastases have comparable survival outcomes following isolated limb infusion or intralesional PV-10-A propensity score matched, single center studyRead, Tavis, Fayers, Warren, Thomas, Janine, Wagels, Michael, Barbour, Andrew and Smithers, B. Mark (2019). Patients with in-transit melanoma metastases have comparable survival outcomes following isolated limb infusion or intralesional PV-10-A propensity score matched, single center study. Journal of Surgical Oncology, 119 (6), 717-727. doi: 10.1002/jso.25373 |
|
2019 Book Chapter Treatment of early oesophageal cancerSmithers, B. Mark and Thomson, Iain (2019). Treatment of early oesophageal cancer. Oesophagogastric Surgery - A Companion to Specialist Surgical Practice. (pp. 89-99) edited by S. Michael Griffin. Edinburgh, Scotland: Elsevier. |
|
2019 Conference Publication Melanoma patient survival: Prognostic value of pSTAT5 as a biomarkerChong, S., Rowe, C., Malt, M., Brown, S., Smithers, M. and Khosrotehrani, K. (2019). Melanoma patient survival: Prognostic value of pSTAT5 as a biomarker. Australasian College of Dermatologists, 52nd Annual Scientific Meeting, Melbourne, VIC Australia, 18–21 May 2019. Richmond, VIC Australia: Wiley-Blackwell. |
|
2019 Conference Publication Phase 1b study of PV-10 and anti-PD-1 in advanced cutaneous melanomaAgarwala, Sanjiv S., Ross, Merrick I., Zager, Jonathan S., Shirai, Keisuke, Essner, Richard, Smithers, Bernard Mark, Atkinson, Victoria and Wachter, Eric Andrew (2019). Phase 1b study of PV-10 and anti-PD-1 in advanced cutaneous melanoma. Annual Meeting of the American Society of Clinical Oncology (ASCO), Chicago, Il, United States, May 31-June 4, 2019. Alexandria, VA, United States: American Society of Clinical Oncology. doi: 10.1200/JCO.2019.37.15_suppl.9559 |
